Colorectal Cancer
Lack of resource ‘equality’ means research of the deadliest cancers is often underfunded
Cancer research and advocacy funding disproportionately skewed toward certain subtypes, leaving many cancers with high mortality rates and those affecting Black patients underfunded, study results in JCO Oncology Practice showed.
Circulating tumor DNA detection may predict treatment outcomes in colorectal cancer
Circulating tumor DNA-based detection of molecular residual disease appeared to be highly prognostic of patient outcomes, according to data presented at ASCO Gastrointestinal Cancers Symposium.
FDA grants breakthrough device designation to Amadix’s blood test for colorectal cancer
The FDA has granted breakthrough device designation to Amadix’s PreveCol, a blood test for early detection of colorectal cancer, intended to screen adults aged 45 years or older without apparent symptoms, according to a company release.
Glecirasib shows ‘impressive’ activity in certain patients with pancreatic cancer
Glecirasib exhibited antitumor activity among patients with pancreatic ductal adenocarcinoma and other solid tumors harboring the KRAS G12C mutation variant, study findings presented at ASCO Gastrointestinal Cancers Symposium showed.
CRC incidence significantly higher among patients with cryptogenic pyogenic liver abscess
Patients diagnosed with cryptogenic pyogenic liver abscess had a “significantly higher incidence” of colorectal cancer up to 3 years from diagnosis compared with matched controls, highlighting the importance of CRC screening, data showed.
Cancer deaths decline overall, but colorectal cancer mortality spike 'has to be addressed'
Cancer mortality in the U.S. is projected to decline again in 2024, but the number of new diagnoses should top 2 million for the first time, an annual report from the American Cancer Society revealed.
Type 2 diabetes drug may reduce colorectal cancer risk
Glucagon-like peptide 1 receptor agonists significantly lowered the risk for colorectal cancer in patients with type 2 diabetes compared with other diabetes medications, according to a research letter in JAMA Oncology.
Vaccine to prevent pancreatic, colorectal cancer relapse yields ‘exciting’ early results
Results of a phase 1 trial for a vaccine targeting micrometastatic disease markers in patients already treated for pancreatic or colorectal cancer showed potential in preventing recurrence, according to a study in Nature Medicine.
Colorectal cancer incidence steadily climbing among younger men vs. women
Colorectal cancer incidence has increased since 1988 among men but not women younger than 50 years, suggesting that patient sex should be factored in when determining screening age, data from an Austrian study showed.
Mortality among homeless veterans with cancer implies ‘lessons to learn’ from VA approach
Homeless veterans with lung or colorectal cancers had higher mortality rates than housed veterans, study data published in JAMA Network Open showed.